J, O., CJ, L., JJ, P., SE, L., MS, K., HJ, C., . . . SM, K. (2022). Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction. ESC heart failure, 9(2), 1492. https://doi.org/10.1002/ehf2.13837
Chicago Style (17th ed.) CitationJ, Oh, et al. "Real-world Eligibility for Vericiguat in Decompensated Heart Failure with Reduced Ejection Fraction." ESC Heart Failure 9, no. 2 (2022): 1492. https://doi.org/10.1002/ehf2.13837.
MLA (9th ed.) CitationJ, Oh, et al. "Real-world Eligibility for Vericiguat in Decompensated Heart Failure with Reduced Ejection Fraction." ESC Heart Failure, vol. 9, no. 2, 2022, p. 1492, https://doi.org/10.1002/ehf2.13837.
Warning: These citations may not always be 100% accurate.